FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for metoprolol succinate (Toprol-XL) under an ANDA from Nivagen Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Ischemic Heart Disease

Drugs mentioned

• TOPROL XL (METOPROLOL SUCCINATE)

Snippet

SUPPL AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)